Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.11.016Source: DataRank Database

The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change is a research paper published in Journal of Thrombosis and Haemostasis (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.63)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Nathalie Tijet,Sandra L. Haberichter ORCID,Veronica H. Flood ORCID,Justyne E Ross ORCID,Colleen Notley ORCID

Live enrichment

PubMed:38040335 PMC:PMC10922911 OpenAlex:https://openalex.org/W4389195591

Canadian Institutes of Health Research

Grant: FDN 154285

National Institutes of Health

Grant: P01HL081588

NHLBI

Grant: P01HL144457

Canadian Institutes of Health Research

Grant: unidentified

unidentified

FWCI

1.63

Citation Percentile

0.9%

Citation Trend

2024

2025

bronzeLicense: Elsevier Non-Commercial

journalhttps://www.jthjournal.org/article/S1538-7836(23)00854-1/pdf

publisherhttps://www.jthjournal.org/article/S1538-7836(23)00854-1/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783623008541?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783623008541?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2023.11.016

Fields of Study

Platelet Disorders and TreatmentsBlood disorders and treatmentsHemophilia Treatment and Research0303 health sciences03 medical and health sciences

MeSH Terms

CanadaHumansPhenotypevon Willebrand Factorvon Willebrand Diseasesvon Willebrand Disease, Type 1

Keywords

Von Willebrand diseaseVon Willebrand factorABO blood group systemPenetrancePopulationGeneticsImmunologyPhenotypeAntigenBiologyMedicineGenePlateletPathogenicityGenetic VariantY1584cCanadavon Willebrand DiseasesHumansvon Willebrand Disease, Type 1

Sustainable Development Goals

SDG 0: Good health and well-being